Microscopic colitis and reproductive factors related to exposure to estrogens and progesterone

Drug Target Insights

Volumn 2013, Issue 7, 2013, Pages 53-62

  Roth, Bodil ^a   Manjer, Jonas ^a   Ohlsson, Bodil ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Estrogen; Microscopic colitis; Progesterone; Reproductive factors

Indexed keywords

ESTROGEN; ORAL CONTRACEPTIVE AGENT; PROGESTERONE;

ADULT; AGED; ARTICLE; COLLAGENOUS COLITIS; CONTROLLED STUDY; DRINKING BEHAVIOR; FEMALE; HORMONE SUBSTITUTION; HUMAN; LYMPHOCYTIC COLITIS; MAJOR CLINICAL STUDY; MATERNAL AGE; MENARCHE; MENOPAUSE; MICROSCOPIC COLITIS; NULLIPARA; OVARIECTOMY; SMOKING;

EID: 84885652374     PISSN: None     EISSN: 11773928     Source Type: Journal    
DOI: 10.4137/DTI.S12889     Document Type: Article

References (33)

1. Rasmussen MA, Munck LK. Systematic review: are lymphocytic colitis and collagenous colitis two subtypes of the same disease-microscopic colitis? Aliment Pharmacol Ther. 2012;36(2):79-90.
2. Pardi DS, Kelly CP. Microscopic colitis. Gastroenterology. 2011;140(4): 1155-65.
3. Karatepe O, Altiok M, Battal M, etal. The effect of progesterone in the prevention of the chemically induced experimental colitis in rats. Acta Cir Bras. 2012;27(1):23-9.
4. Günal O, Oktar BK, Ozçinar E, Sungur M, Arbak S, Yeǧen B. Estradiol treatment ameliorates acetic acid-induced gastric and colonic injuries in rats. Inflammation. 2003;27(6):351-9.
5. Moussa L, Bézirard V, Salvador-Cartier C, etal. A low dose of fermented soy germ alleviates gut barrier injury, hyperalgesia and faecal protease activity in a rat model of inflammatory bowel disease. PLoS ONE. 2012;7(11): e49547.
6. Carmack SW, Lash RH, Gulizia JM, Genta RM. Lymphocytic disorders of the gastrointestinal tract: a review for the practicing pathologist. Adv Anat Pathol. 2009;16:290-306.
7. Manjer J, Carlsson S, Elmståhl S, etal. The Malmö Diet and Cancer Study: representativity, cancer incidence and mortality in participants and non-participants. Eur J Cancer Prev. 2001;10(6):489-99.
8. Manjer J, Elmståhl S, Janzon L, Berglund G. Invitation to a population-based cohort study: differences between subjects recruited using various strategies. Scand J Public Health. 2002;30(2):103-12.
9. Manjer J, Johansson R, Berglund G, etal. Postmenopausal breast cancer risk in relation to sex steroid hormones, prolactin and SHBG (Sweden). Cancer Causes Control. 2003;14(7):599-607.
10. Almquist M, Bondeson AG, Bondeson L, Malm J, Manjer J. Serum levels of vitamin D, PTH and calcium and breast cancer risk-a prospective nested case-control study. Int J Cancer. 2010;127(9):2159-68.
11. Henriksen M, Jahnsen J, Lygren I, etal. Ibsen Study Group. Change of diagnosis during the first five years after onset of inflammatory bowel disease: results of a prospective follow-up study (the IBSEN Study). Scand J Gastroenterol. 2006;41(9):1037-43.
12. Roth B, Manjer J, Ohlsson B. Microscopic colitis is associated with several concomitant diseases. Drug Target Insights. 2013;7:19-25.
13. Butt S, Harlid S, Borgquist S, etal. Genetic predisposition, parity, age at first childbirth and risk for breast cancer. BMC Res Notes. 2012;5:414.
14. Olesen M, Eriksson S, Bohr J, Järnerot G, Tysk C. Lymphocytic colitis: a retrospective clinical study of 199 Swedish patients. Gut. 2004;53(4):536-41.
15. Fernández-Bañares F, Salas A, Forné M, Esteve M, Espinós J, Viver JM. Incidence of collagenous and lymphocytic colitis: a 5-year population-based study. Am J Gastroenterol. 1999;94(2):418-23.
16. Münch A, Aust D, Bohr J, etal; European Microscopic Colitis Group (EMCG). Microscopic colitis: Current status, present and future challenges: statements of the European Microscopic Colitis Group. J Crohns Colitis. 2012;6(9):932-45.
17. González DA, Díaz BB, Rodríguez Pérez Mdel C, Hernández AG, Chico BN, de León AC. Sex hormones and autoimmunity. Immunol Lett. 2010;133(1): 6-13.
18. Cornish JA, Tan E, Simillis C, Clark SK, Teare J, Tekkis PP. The risk of oral contraceptives in the etiology of inflammatory bowel disease: a meta-analysis. Am J Gastroenterol. 2008;103(9):2394-400.
19. Khalili H, Higuchi LM, Ananthakrishnan AN, etal. Hormone therapy increases risk of ulcerative colitis but not Crohn's disease. Gastroenterology. 2012;143(5):1199-206.
20. Cappell MS. Colonic toxicity of administered drugs and chemicals. Am J Gastroenterol. 2004;99(6):1175-90.
21. Konstantinopoulos PA, Kominea A, Vandoros G, etal. Oestrogen receptor beta (ERbeta) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour's dedifferentiation. Eur J Cancer. 2003;39(9):1251-8.
22. Xiao ZL, Pricolo V, Biancani P, Behar J. Role of progesterone signaling in the regulation of G-protein levels in female chronic constipation. Gastroenterology. 2005;128(3):667-75.
23. Cong P, Pricolo V, Biancani P, Behar J. Abnormalities of prostaglandins and cyclooxygenase enzymes in female patients with slow-transit constipation. Gastroenterology. 2007;133(2):445-53.
24. O'Mahony F, Alzamora R, Betts V, etal. Female gender-specific inhibition of KCNQ1 channels and chloride secretion by 17beta-estradiol in rat distal colonic crypts. J Biol Chem. 2007;282(34):24563-73.
25. Wada-Hiraike O, Imamov O, Hiraike H, etal. Role of estrogen receptor beta in colonic epithelium. Proc Natl Acad Sci U S A. 2006;103(8):2959-64.
26. Turner JR. Molecular basis of epithelial barrier regulation: from basic mechanisms to clinical application. Am J Pathol. 2006;169(6):1901-9.
27. Meddings JB. Review article: Intestinal permeability in Crohn's disease. Aliment Pharmacol Ther. 1997;11 Suppl 3:47-53.
28. Teshima CW, Dieleman LA, Meddings JB. Abnormal intestinal permeability in Crohn's disease pathogenesis. Ann N Y Acad Sci. 2012;1258:159-65.
29. Braniste V, Leveque M, Buisson-Brenac C, Bueno L, Fioramonti J, Houdeau E. Oestradiol decreases colonic permeability through oestrogen receptor beta-mediated up-regulation of occludin and junctional adhesion molecule-A in epithelial cells. J Physiol (Lond). 2009;587(Pt 13):3317-28.
30. Stroehlein JR. Microscopic colitis. Curr Treat Options Gastroenterol. 2007;10(3):231-6.
31. Roth B, Gustafsson RJ, Ohlsson B. Auto-antibodies and their association with clinical findings in women diagnosed with microscopic colitis. PLoS ONE. 2013;8(6):e66088.
32. Roth B, Bengtsson M, Ohlsson B. Diarrhoea is not the only symptom that needs to be treated in patients with microscopic colitis. Eur J Intern Med. 2013;24:573-8.
33. Królik M, Milnerowicz H. The effect of using estrogens in the light of scientific research. Adv Clin Exp Med. 2012;21(4):535-43.